MARLETT CHRISTOPHER A 13D and 13G filings for Cue Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-01 5:21 pm Purchase | 2021-07-25 | 13D | Cue Biopharma, Inc. CUE | MARLETT CHRISTOPHER A | 18,854,933 68.200% | 18,854,933 (New Position) | Filing |